Introduction
Human leukocyte antigens (HLA) are glycoproteins that are present on the surface membranes of nearly every cell in the body and are on chromosome number six. Their main function is to help the immune system defend against invaders such as bacteria, viruses, and parasites as well as against cancers. In cases of cancers, however, many reports that evaluated the serological or DNAtyping HLA antigens failed to confirm that the HLA antigens are responsive to cancers. We previously reported that based on a study of 3,219 Japanese individuals that cancer subjects showed a significantly lower frequency of HLA-A33, -B44, and -DR9 than non-cancer subjects 1) .
In this study, we re-examined serological HLA typing to clarify the association between cancer risk and HLA antigens in Japanese people. To our knowledge, this is
HLA typing
HLA antigens were serologically tested using the NIH standard microlymphocytotoxicity method for HLA-A, B, C, DR and DQ antigens. Eight HLA-A antigens, 20 HLA-B antigens, 5 HLA-C antigens, 12 HLA-DR antigens, and 4 HLA-DQ antigens were examined.
Heparinized peripheral blood samples were obtained from a number of research groups, transferred to a single reference laboratory, and centrifuged for 5 min at 2000 RPM. After collecting the buffy coat, B lymphocytes were separated from T lymphocytes using the nylon wool adherence method and HLA class I and II Dynabeads (Dynal AS, Oslo, Norway). Peripheral blood lymphocytes were separated by layering them onto Lymphoprep (Nycomed, Oslo, Norway), followed by centrifugation. For class I typing, cryopreserved peripheral blood lymphocytes were subjected to a complement-dependent microcytotoxicity assay using antisera to HLA-A, -B and -C locus antigens. Class II typing was carried out on cells enriched for class II-positive lymphocytes using magnetic beads coated with a class II monoclonal antibody (Dynal). These cells were subjected to a complement-dependent microcytotoxicity assay using antisera to HLA-DR and -DQ antigens. 
Statistical analysis
All of the statistical analyses that follows was carried out using SPSS software, version 13 (SPSS Inc., Chicago, USA.). The chi-square test with the Bonferroni correction was used to compare the prevalence of the incidence of HLA antigens; Fisher's exact test was used if the number was less than 5. The odds ratio (relative risk (RR)) and 95% confidence intervals (CI) were calculated. Results were considered significant when the value was less than 0.05.
Results
The most frequent specificities were HLA-DQ1 (phenotype frequency = 33.3%) followed by HLA-DQ3 (29.7%), HLA-A24 (29.6%), HLA-Cw3 (23.1%), HLA-A2 (20.5%), HLA-DR4 (19.3%) and HLA-DR2 (17.4%). Among non-cancer, normal subjects and cancer patients, there were significantly lower frequencies for HLA-24, -A33, -B35, -B44, -DR8, and -DR9, but there was only one significantly lower frequency for HLA-DR8 even after the Bonferroni correction.
In patients with gastric cancer, there was a significantly lower frequency for HLA-A33 and -B44 than for non-cancer subjects even after the Bonferroni correction. In the case of esophageal cancer, significantly lower frequencies for HLA-A33, -B44, -DR6, -DR8, and -DQ4 were found. In cases of hepatoma, the frequency of HLA-DQ3 was significantly lower. In cases of lung cancer, the frequencies of HLA-DR8 and DQ4 were also significantly lower after the Bonferroni correction. The same was true in cases of breast cancer for frequencies of HLA-Cw3, -DR8, and -DR9.
Discussion
It has been proposed that disease-associated imbalances in HLA allele frequencies between diseased and healthy populations may signify efficient immune responses 2) . It has also been well known that HLA antigen expression loss in malignant cells has been demonstrated by immunohistochemistry. Abnormally decreased HLA antigen expression may not permit the immune system to avoid or survive an attack, and consequently the clinical course of a disease would be not so good.
Wank et al. reported an association between squamous cell carcinoma of the cervix for women and HLA-DQw3 3) . Cancer diseases whose carcinogenesis may be induced by viral infections such as squamous cell carcinoma of the cervix for women or head and neck carcinoma have been associated with HLA antigen 4, 5) , but others failed to have been significantly associated with HLA antigens.
In the case of gastric cancer, Lee et al. reported that the frequency of HLA-DQB1*0301 in patients with gastric adenocarcinoma was higher than in controls but were not associated with colorectal or pancreatic adenocarcinoma 6) . Ohmori et al. reported that after the Bonferroni correction the difference in frequencies of HLA alleles and haplotypes between gastric cancer patients and controls was of no statistical significance 7) .
We reported that among cancer patients the frequencies of HLA-A33, -B44, and -DR9 were lower, but the hypothesis of overdominant selection ("heterozygote advantage") at MHC has more correlation with carcinogenesis 2) . It has been suggested that the hypothetical advantage of heterozygosity at HLA with respect to increased resistance to cancer may be responsible, at least Table continued in part, for maintaining the tremendous variety of HLA alleles that exists in the human population 8) . On the other hand, we also reported that the HLA-Cw3 antigen resulted from subsequent malignancies after gastrectomy in cases of gastric cancer 9) . The data demonstrated here shows that there may be an association between different cancers and different antigens. The frequencies of HLA-A33, -B44, -Cw3, -DR6, -DR8, -DR9 and -DQ4 antigens were lower in total. Therefore, they may be act as defensive factors of carcinogenesis.
